INDV
NASDAQ · Pharmaceuticals
Indivior Pharmaceuticals Inc
$39.50
-0.10 (-0.25%)
Performance
1D
—
1W
—
1M
—
3M
+16.66%
6M
+27.91%
1Y
+256.50%
YTD
+10.55%
Open$39.78
Previous Close$39.60
Day High$40.05
Day Low$39.01
52W High$41.00
52W Low$10.63
Volume—
Avg Volume3.08M
Market Cap4.83B
P/E Ratio22.99
EPS$1.63
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$34.90
Above
SMA 200
$24.61
Above
RSI (14)
47.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
13 analysts
Price Target
+22.8% upside
Current
$39.50
$39.50
Target
$48.50
$48.50
$40.68
$48.50 avg
$71.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.18B | 1.06B | 1.33B |
| Net Income | 200.53M | 162.30M | 235.99M |
| Profit Margin | 17.0% | 16.1% | 17.8% |
| EBITDA | 250.19M | 213.74M | 342.24M |
| Free Cash Flow | — | — | 277.67M |
| Rev Growth | +11.2% | +11.2% | +22.2% |
| Debt/Equity | 5.43 | 5.43 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |